Emerging Agents in the Pipeline for Merkel Cell Carcinoma
2 Просмотры
administrator
07/17/23
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses emerging agents in the pipeline for Merkel cell carcinoma.
Показать больше
Комментарии Facebook
Комментариев нет